Cargando…
Deterioration of bladder compliance after botulinum toxin A injection and discontinuation of medication for overactive bladder
INTRODUCTION: We report a case of deterioration of bladder compliance after botulinum toxin type A injection and discontinuation of medication for overactive bladder. CASE PRESENTATION: A female patient with overactive bladder in her sixties had been visiting our outpatient clinic regularly for 4 ye...
Autores principales: | Wada, Naoki, Ishikawa, Mayumi, Nagabuchi, Masaya, Makino, Shogo, Miyauchi, Kotona, Abe, Noriyuki, Kakizaki, Hidehiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436694/ https://www.ncbi.nlm.nih.gov/pubmed/36090943 http://dx.doi.org/10.1002/iju5.12496 |
Ejemplares similares
-
High-Fat and High-Sucrose Diet Leads to Skeletal Muscle Loss and Bladder Dysfunction in Rat
por: Wada, Naoki, et al.
Publicado: (2023) -
Botulinum toxin A for the Treatment of Overactive Bladder
por: Hsieh, Po-Fan, et al.
Publicado: (2016) -
Relationship between overactive bladder and irritable bowel syndrome: a large-scale internet survey in Japan using the overactive bladder symptom score and Rome III criteria
por: Matsumoto, Seiji, et al.
Publicado: (2013) -
Drugs for the overactive bladder: are there differences in persistence and compliance?
por: Andersson, Karl-Erik
Publicado: (2017) -
The use of botulinum toxin for the treatment of overactive bladder syndrome
por: Orasanu, Bogdan, et al.
Publicado: (2013)